BioCentury
ARTICLE | Clinical News

TheraBiologics, University of Chicago, City of Hope preclinical data

September 2, 2013 7:00 AM UTC

In a mouse model of GBM, TBX-03 in combination with temozolomide and radiation increased median survival by about 46%. Additionally, TBX-03 delivered prior to temozolomide and radiation increased medi...